Therefore, the semi-acute administration of NaHS may act as a neurotherapeutic agent through multiple pathophysiological mechanisms, including antioxidative, anti-inflammatory, anti-reactive gliosis, and reduce amyloid deposition and tau hyperphosphorylation in the multifactorial pathogenesis of AD. Here, MAPT is linked to Alzheimer disease.